This page reprints a manufacturer label. Everything below in quotation marks is copied from OZIPCO Fenbendazole CAT DEWORMER, published by FDA and retrieved on 2026-09-16. Nothing has been added, reworded or left out of the sections shown. It is the manufacturer’s label, reproduced as published.
This page reprints the FDA label for OZIPCO Fenbendazole CAT DEWORMER by Fast Sold LLC, a praziquantel and pyrantel product labelled for dogs and cats. The sections below are copied from that label without change, with the set id and the date it was retrieved from DailyMed.
The label
Product: OZIPCO Fenbendazole CAT DEWORMER. Manufacturer: Fast Sold LLC. FDA Structured Product Label set id 686ace23-bd62-424a-9577-20a15a5aacfb. Label effective 2026-08-30. Retrieved 2026-09-16 from the DailyMed animal label release, and readable on DailyMed.
Indications
Praziquantel/Pyrantel Pamoate Tablets are a broad-spectrum dewormer for the removal and control of tapeworms, roundworms, and hookworms in cats and kittens.
Dosage and Administration
To ensure proper dosage, weigh the cat prior to treatment. Administer as a single oral dose according to the following table. DOSAGE TABLE: Body Weight: 2–3 lbs Number of Tablets: 0.5 tablet Body Weight: 4–8 lbs Number of Tablets: 1.0 tablet Body Weight: 9–12 lbs Number of Tablets: 1.5 tablets Body Weight: 13–16 lbs Number of Tablets: 2.0 tablets Not for use in kittens less than 2 months of age or weighing less than 2 lbs. DIRECTIONS FOR USE: Tablets may be given directly by mouth or offered in a small amount of food. Do not withhold food from the cat prior to or after treatment. RETREATMENT: Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. Re-treatment may be necessary as determined by your veterinarian. Store at 20–25°C (68–77°F). DISTRIBUTED BY: OZIPCO® Fast Sold LLC For OZIPCO 2280 AVOCADO AVE SUITE 5 MELBOURNE, FL 32935-5547 United States Telephone: +1-929-822-0639 Email: support@ozipco.us Website: www.ozipco.us PACKAGE LABEL.PRINCIPAL DISPLAY PANEL OZIPCO PET HEALTH CARE CAT DEWORMER BROAD SPECTRUM Dewormer For CATS AND KITTENS (2 lbs to 16 lbs) For the treatment and control of: Tapeworms Hookworms Large Roundworms (Praziquantel/Pyrantel Pamoate) Tablets EACH TABLET CONTAINS: 18.2 mg Praziquantel 72.6 mg Pyrantel Base as Pyrantel Pamoate 50 TABLETS KEEP OUT OF REACH OF CHILDREN NOT FOR HUMAN USE Dog dewormer Liquid
Warnings
Keep out of reach of children. CAUTIONS: Do not use in kittens less than 8 weeks of age or weighing less than 2 lbs. Use with caution in sick or debilitated animals. Consult your veterinarian before administering to sick or pregnant animals.
FDA adverse event reports
The FDA Center for Veterinary Medicine publishes the adverse event reports it receives through openFDA. The counts below are the reports naming praziquantel and pyrantel as an active ingredient for each species this label names, as returned on 2026-09-16, coded by the VeDDRA reaction term the reporter chose. Reactions are counted per report, so one report can appear under several terms.
These are counts, not rates. Reporting is voluntary, the number of animals treated is not known, and a widely used product accumulates reports for that reason alone. A report records that an event followed a dose; it does not establish that the product caused it. The counts say nothing about how one product compares with another.
Dogs: 22,421 reports
| VeDDRA reaction term | Reports |
|---|---|
| Vomiting | 8,237 |
| Diarrhoea | 2,653 |
| Lethargy (see also Central nervous system depression in 'Neurological') | 1,899 |
| Lack of efficacy (endoparasite) - heartworm | 1,581 |
| INEFFECTIVE, HEARTWORM LARVAE | 1,479 |
| Lack of efficacy (endoparasite) - hookworm | 1,443 |
| Emesis | 1,004 |
| Lack of efficacy - NOS | 990 |
| Lack of efficacy (endoparasite) - tapeworm | 965 |
| Emesis (multiple) | 955 |
| Anorexia | 752 |
| Behavioural disorder NOS | 625 |
| Overdose | 589 |
| Not eating | 541 |
| INEFFECTIVE, ASCARIDS NOS | 537 |
Outcome as recorded by the reporter: Outcome Unknown 9,154; Recovered/Normal 8,542; Ongoing 1,381; Died 528; Euthanized 137; Recovered with Sequela 113.
Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.
Cats: 1,407 reports
| VeDDRA reaction term | Reports |
|---|---|
| Ataxia | 454 |
| Vomiting | 342 |
| Lethargy (see also Central nervous system depression in 'Neurological') | 138 |
| Anorexia | 113 |
| Hypersalivation | 89 |
| Diarrhoea | 86 |
| Behavioural disorder NOS | 82 |
| Emesis | 79 |
| Depression | 72 |
| Lack of efficacy (endoparasite) - tapeworm | 64 |
| Death | 61 |
| Other abnormal test result NOS | 46 |
| Weight loss | 43 |
| Lethargy (see also Central nervous system depression in Neurological) | 41 |
| Emesis (multiple) | 40 |
Outcome as recorded by the reporter: Recovered/Normal 534; Outcome Unknown 387; Ongoing 110; Died 71; Euthanized 27; Recovered with Sequela 2.
Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.
Sources
- OZIPCO Fenbendazole CAT DEWORMERFDA · retrieved 2026-09-16
“To ensure proper dosage, weigh the cat prior to treatment.” (Dosage and Administration)
- openFDA Animal and Veterinary Adverse Event ReportsFDA · retrieved 2026-09-16
Related
From Glarda
The note drafted from the consult, with the reference you just read sitting beside it in the shape your record already expects.